Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 713

1.

Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.

Evenepoel P, Selgas R, Caputo F, Foggensteiner L, Heaf JG, Ortiz A, Kelly A, Chasan-Taber S, Duggal A, Fan S.

Nephrol Dial Transplant. 2009 Jan;24(1):278-85. doi: 10.1093/ndt/gfn488. Epub 2008 Sep 27.

PMID:
18820280
[PubMed - indexed for MEDLINE]
Free Article
2.

A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients.

Liu YL, Lin HH, Yu CC, Kuo HL, Yang YF, Chou CY, Lin PW, Liu JH, Liao PY, Huang CC.

Ren Fail. 2006;28(8):701-7.

PMID:
17162430
[PubMed - indexed for MEDLINE]
3.

Sevelamer hydrochloride in peritoneal dialysis patients: results of a multicenter cross-sectional study.

Ramos R, Moreso F, Borras M, Ponz E, Buades JM, Teixidó J, Morey A, Garcia C, Vera M, Doñate MT, de Arellano MR, Barbosa F, González MT.

Perit Dial Int. 2007 Nov-Dec;27(6):697-701.

PMID:
17984434
[PubMed - indexed for MEDLINE]
Free Article
4.

Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.

Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GF.

Am J Kidney Dis. 2009 Oct;54(4):619-37. doi: 10.1053/j.ajkd.2009.06.004. Epub 2009 Aug 18. Review.

PMID:
19692157
[PubMed - indexed for MEDLINE]
5.

Sevelamer hydrochloride: a review of its use for hyperphosphataemia in patients with end-stage renal disease on haemodialysis.

Goldsmith DR, Scott LJ, Cvetković RS, Plosker GL.

Drugs. 2008;68(1):85-104. Review.

PMID:
18081374
[PubMed - indexed for MEDLINE]
6.

Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.

Lin YF, Chen YM, Hung KY, Chu TS, Kan WC, Huang CY, Lin SL, Kao TW, Huang JW, Chiang WC, Yen CJ, Tsai TJ, Wu KD, Wu MS.

J Formos Med Assoc. 2010 Sep;109(9):663-72. doi: 10.1016/S0929-6646(10)60107-6.

PMID:
20863994
[PubMed - indexed for MEDLINE]
7.

Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.

Takei T, Otsubo S, Uchida K, Matsugami K, Mimuro T, Kabaya T, Akiba T, Nitta K.

Nephron Clin Pract. 2008;108(4):c278-83. doi: 10.1159/000127361. Epub 2008 Apr 22.

PMID:
18434749
[PubMed - indexed for MEDLINE]
8.

Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis.

Ketteler M, Rix M, Fan S, Pritchard N, Oestergaard O, Chasan-Taber S, Heaton J, Duggal A, Kalra PA.

Clin J Am Soc Nephrol. 2008 Jul;3(4):1125-30. doi: 10.2215/CJN.05161107. Epub 2008 May 1.

PMID:
18450923
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.

Qunibi W, Moustafa M, Muenz LR, He DY, Kessler PD, Diaz-Buxo JA, Budoff M; CARE-2 Investigators.

Am J Kidney Dis. 2008 Jun;51(6):952-65. doi: 10.1053/j.ajkd.2008.02.298. Epub 2008 Apr 18.

PMID:
18423809
[PubMed - indexed for MEDLINE]
10.

Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability.

de Francisco AL, Leidig M, Covic AC, Ketteler M, Benedyk-Lorens E, Mircescu GM, Scholz C, Ponce P, Passlick-Deetjen J.

Nephrol Dial Transplant. 2010 Nov;25(11):3707-17. doi: 10.1093/ndt/gfq292. Epub 2010 Jun 7.

PMID:
20530499
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.

Ahmadi F, Shamekhi F, Lessan-Pezeshki M, Khatami MR.

Saudi J Kidney Dis Transpl. 2012 Sep;23(5):934-8. doi: 10.4103/1319-2442.100865.

PMID:
22982903
[PubMed - indexed for MEDLINE]
Free Article
12.

RenaGel efficacy in severe secondary hyperparathyroidism.

Castro R, Herman A, Ferreira C, Travassos F, Nunes-Azevedo J, Oliveira M.

Nefrologia. 2002;22(5):448-55.

PMID:
12497746
[PubMed - indexed for MEDLINE]
13.

A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.

Prajapati VA, Galani VJ, Shah PR.

Saudi J Kidney Dis Transpl. 2014 May;25(3):530-8.

PMID:
24821148
[PubMed - indexed for MEDLINE]
Free Article
14.
15.

Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.

Brandenburg VM, Schlieper G, Heussen N, Holzmann S, Busch B, Evenepoel P, Vanholder R, Meijers B, Meert N, Fassbender WJ, Floege J, Jahnen-Dechent W, Ketteler M.

Nephrol Dial Transplant. 2010 Aug;25(8):2672-9. doi: 10.1093/ndt/gfq053. Epub 2010 Feb 18.

PMID:
20172849
[PubMed - indexed for MEDLINE]
Free Article
16.

Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: a comparison with calcium acetate.

Hervás JG, Prados D, Cerezo S.

Kidney Int Suppl. 2003 Jun;(85):S69-72.

PMID:
12753270
[PubMed - indexed for MEDLINE]
17.

A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD.

Pieper AK, Haffner D, Hoppe B, Dittrich K, Offner G, Bonzel KE, John U, Fründ S, Klaus G, Stübinger A, Düker G, Querfeld U.

Am J Kidney Dis. 2006 Apr;47(4):625-35.

PMID:
16564940
[PubMed - indexed for MEDLINE]
18.

Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.

Brewster UC, Ciampi MA, Abu-Alfa AK, Reilly RF.

Nephrology (Carlton). 2006 Apr;11(2):142-6.

PMID:
16669977
[PubMed - indexed for MEDLINE]
19.

RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group.

Slatopolsky EA, Burke SK, Dillon MA.

Kidney Int. 1999 Jan;55(1):299-307.

PMID:
9893140
[PubMed - indexed for MEDLINE]
Free Article
20.

Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study).

Qunibi WY, Hootkins RE, McDowell LL, Meyer MS, Simon M, Garza RO, Pelham RW, Cleveland MV, Muenz LR, He DY, Nolan CR.

Kidney Int. 2004 May;65(5):1914-26.

PMID:
15086935
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk